A CRISPR screen has identified the histone methyltransferase SUV39H2 as a key mediator of resistance to oncolytic herpes simplex virus 1 (oHSV-1) in oral squamous cell carcinoma (OSCC). This discovery, detailed in Cell Death Discovery, provides a new molecular target for enhancing oHSV-1-based cancer therapies.